{"id":789894,"date":"2026-02-10T15:23:01","date_gmt":"2026-02-10T15:23:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=789894"},"modified":"2026-02-10T15:23:01","modified_gmt":"2026-02-10T15:23:01","slug":"global-medical-aesthetics-market-to-reach-usd-4070-billion-by-2031-driven-by-surge-in-minimally-invasive-procedures","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/global-medical-aesthetics-market-to-reach-usd-4070-billion-by-2031-driven-by-surge-in-minimally-invasive-procedures_789894.html","title":{"rendered":"Global Medical Aesthetics Market to Reach USD 40.70 Billion by 2031, Driven by Surge in Minimally Invasive Procedures"},"content":{"rendered":"
\"Global<\/a><\/div>\n
Global Medical Aesthetics Market by Product (Botox, Filler, Peel, Liposuction, Microneedling, Hair Removal, Laser Resurfacing, RF, Phototherapy), Procedure (Surgical, Non-surgical), End User (Hospital, Beauty Clinic, Spa), and Region \u2013 Global Forecast to 2031<\/div>\n

According to a new research report titled “Global Medical Aesthetics Market by Product, Procedure, End User, and Region – Global Forecast to 2031”<\/strong>, the global medical aesthetics market is projected to grow from USD 19.54 billion in 2025 to USD 40.70 billion by 2031<\/strong>, registering a compound annual growth rate (CAGR) of 13.0%<\/strong> during the forecast period.<\/p>\n

The report provides comprehensive analysis of the medical aesthetics market across products, procedures, end users, and regions<\/strong>, supported by 350 data tables, 90 figures, and 390 pages<\/strong> of in-depth market intelligence. It offers actionable insights into growth drivers, competitive dynamics, and emerging trends shaping the future of the global medical aesthetics industry.<\/p>\n

Download PDF Brochure:- https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=885<\/a><\/strong><\/p>\n

Rising disposable incomes, expanding urban populations, the influence of social media, and an aging yet appearance-conscious demographic are further accelerating demand across both developed and emerging economies.<\/p>\n

Facial Aesthetics Products Dominate the Market by Product<\/strong><\/p>\n

By product, the medical aesthetics market is segmented into facial aesthetic products, cosmetic implants, skin aesthetic devices, body contouring devices, physician-dispensed cosmeceuticals and skin lighteners, hair removal devices, tattoo removal devices, thread lift products, physician-dispensed eyelash products, and nail treatment laser devices.<\/p>\n

In 2025, facial aesthetic products accounted for the largest share of the global market, driven by their broad patient applicability, high procedure volumes, and strong alignment with consumer demand for visible, non-surgical enhancements. Treatments addressing wrinkles, volume loss, skin laxity, pigmentation, and texture irregularities are often the first aesthetic interventions sought by patients, making facial aesthetics a key entry point into the market. Widespread adoption across age groups and genders, supported by increasing social acceptance and digital visibility, continues to fuel segment growth.<\/p>\n

Dermatology Clinics, Hospitals, and Medical Spas Lead by End User<\/strong><\/p>\n

By end user, the global medical aesthetics market is categorized into dermatology clinics, hospitals, medical spas, beauty centers, and home care settings. In 2025, dermatology clinics, hospitals, and medical spas are estimated to dominate the market, reflecting rising consumer preference for professional, medically supervised aesthetic treatments.<\/p>\n

Growth in this segment is supported by increasing demand for non-surgical procedures such as Botox and dermal fillers, advancements in non-invasive technologies that enhance precision and safety, and a growing middle- and upper-income population willing to invest in aesthetic wellness. Additionally, the expanding participation of men in aesthetic treatments is contributing to higher procedure volumes across clinical settings.<\/p>\n

Request For Sample Pages:- https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=885<\/a> <\/strong><\/p>\n

North America Leads the Global Medical Aesthetics Market<\/strong><\/p>\n

In 2025, North America is estimated to account for the largest share of the global medical aesthetics market. The region benefits from high penetration of premium-priced aesthetic procedures, a large base of board-certified aesthetic professionals, and strong adoption of advanced and regenerative aesthetic therapies. Growing demand for combination treatments, high consumer awareness, and expanding medical tourism hubs in select cities further strengthen North America’s leadership position.<\/p>\n

The market’s strong expansion is driven by the rapid shift toward minimally invasive and non-surgical aesthetic procedures, growing aesthetic awareness across age groups and genders, and continuous innovation in injectables, energy-based devices, and combination treatment approaches. Improved safety profiles, predictable clinical outcomes, and increasing acceptance of aesthetic treatments as part of routine self-care and wellness have transformed medical aesthetics from an elective cosmetic service into a mainstream healthcare offering.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> MarketsandMarkets\u2122 Research Private Ltd.<\/a>
Contact Person:<\/strong> Mr. Rohan Salgarkar
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 18886006441
Address:<\/strong>1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City:<\/strong> Florida
State:<\/strong> Florida
Country:<\/strong> United States
Website:<\/strong> https:\/\/www.marketsandmarkets.com\/Market-Reports\/medical-aesthetics-market-885.html<\/a><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Global Medical Aesthetics Market by Product (Botox, Filler, Peel, Liposuction, Microneedling, Hair Removal, Laser Resurfacing, RF, Phototherapy), Procedure (Surgical, Non-surgical), End User (Hospital, Beauty Clinic, Spa), and Region \u2013 Global Forecast to 2031 According to a new research report titled … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[405,406,420,403,404],"tags":[],"class_list":["post-789894","post","type-post","status-publish","format-standard","hentry","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-Science","category-UK","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/789894","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=789894"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/789894\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=789894"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=789894"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=789894"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}